MS; PES Piramal Critical Care
Isoflurane, USP
1) PRODUCT AND COMPANY IDENTIFICATION
Product name: Isoflurane, USP
Synonyms! Terell
Atane
Tsolurane
Escain
Isofane
Isofluran
r [eoflurana
4-CHLORO-2.2,2-TRIFLUOROETHYL DIFLUOROMETHYL ETHER
CAS Number: 26675-46-7
Formul CHF,OCCIHCFs
(Chemical Family: Anesthetic, Halogenated Ether
Manufacture Piramal Critical Care
3950 Schelden Circle
Bethlehem, PA 18017
24 Hour Emergency Number: (CHEMTREC 1-703-527-3887
2) COMPOSITION/IINFORMATION ON INGREDIENTS
Component Weight Classification
Tsoflurane 100 "None
3) HAZARDS IDENTIFICATION
Emergency Overview: CAUTION! Anesthetic Agent. Overexposure by inhalation tothe vapors may
‘cause temporary nervous system depression with anesthetic effects such as
dizziness, headache, confusoa, coordination, or loss of conciousoess, they
should be moved o an area of fresh ar. Concentrations of anesthetic inte air
‘would have to reach approximately 2-3 Ye before personnel would be expected
{wexperience significant dizziness, Gross overexposure (> 20%) may possibly
alter the hearts electrical ativity wth iregular pulse, palptationsor inadequate
@ circulation
Exposure Routes: Inhalation. Skin contact. Fye contact. Ingestion,
Inhalation: Practically non-toxic by inkalation, Cardiovascular effects may include
‘yetuaions in heat rte, changes in blood preste, chest pin. Respiratory
effects may include shoriness of breath, bronchospasm, aryngospsms,
respiratory depression, Gastrointestinal effects may include pause, upset
stomach, los of appetite. Nervous system eflecs may include ataxia, tremor,
disturbance of speech, lethargy, headaches, dizziness, blued vision,
Skin Contact: May cause skin invitation,
Eye Contact: May cause eye irritation
Ingestion: Practically non-tosie if swallowed, No spesific hazards other than therapeutic
fects. See inhalation,
D FIRST AID MEASURES
Pree otInhalation: thigh concentrations ae inhaled, immediately remove to fresh ai. IFnot
breathing, perform artificial respiration. Keop the affected person warm and
atest, Get medical attention as soon as possible
‘Skin Contact: Incase of contet, remove contaminated clothing, and wash contaminated
skin with sogp and water. Seck medical atenion if initation is present.
Eye Cont
Incase of contact, immediately wash (tigate) the eyes with large amounts of
tepid potable water, occasionally iting the lower and upper lis. Get medical
atcntion immediately.
Ingestion: DO NOT induce vomiting unless directed to do so by medical personne
[Never give anything by mouth 1 an unconscious person. If large quantities
are swallowed, get medical attention immediately.
Note to Physician: Due othe possible disturbances of cardiac shythm, catecholamine drugs,
such as epinephrine, should be considered only a last reson in life-
threatening emergencies.
@ 5 FIREFIGHTING MEASURES
Flash Point: [Not determined
Specific Methods: 'No information available
Flammable Limits in air-lower (%): Not available
Flammable Limits ln alt-upper (7):
‘Autoignition:
Extinguishing Medi Use extinguishing media appropriate wo surrounding fire conditions
Fire Fighting Instructions: Fire fighters and others should wear NIOSH approved positive pressure sel
contained breathing apparatus (SCBA) and turnout gear.
Fire and Explosion Hazard: Use water spray to cool containers. Containers may rupture under fire
conditions
9) ACCIDENTAL RELEASE MEASURES
In Case of Spill or Leal
‘Small volumes of liquid anesthetic agents may readily evaporate at room
temperatures and aay dissipate before any clean up attempts ae initiated.
Fer large spills, provide adequate ventilation or evacuate area. Large quantities
of anesthetic agents may cause sedative effects. Restit personnel not
donning protective equipment from areas of spills or leaks until clear up is
complete. A sorbent designed for organic chemicals shouldbe use for large
spills. Spill pillows, vermiculite, ad earbon-based sorbents are examples of
Suitable materials. Dike spill and prevent liquid from entering sewers,
watervays or low areas. Sweep of Scoop up and remove toa suitable
container. Close container and dispose of container in accordance with
e {Sista lee elton
7) HANDLING AND STORAGE
Mandi Wash thorough ater hing
Sura: Kec conan th sealed Soe in ay col, and wll veiled place
Store berween 15~ 30°C (39 - 86°F)
8) EXPOSURE CONTROLS/PERSONAL PROTECTION
Engineering Controls: Investigate engineering techniques, process enclosures or local exhaust
ventlation to keep airborne levels below recommended exposure limit
Bye Protection: Safety glasses, chemical splash goggles, face shield, or other fll faced
protetion should be available for use if potential exist for exposure 0
splashes,
‘Skin Protect (Chemical resistant, impervious gloves should be use to avoid prolonged or
ee decRespiratory Protect
‘OSHA-Time Weighted Average:
‘OSHA-Short Term Exposure Limit:
(OSHA-Ceiling Limits:
ACGII-Time Weighted Average:
ACGHEShort Term Exposure Limit:
‘ACGIH-Ceiting Limit Value:
NIOSH REL!
repeated exposure, Wear a work uniform or laboratory coat. Additional body
fgrments should be used based upon the tasks being performed.
‘When working with small quantities in a well ventilated area, respiratory
protection may not be required. Ir exposure levels exceed regulatory limit,
Implement a respiratory protection program that isin compliance with OSHA.
29 CFRI910.134 or equivalent in eter rgions. Firefighting requires the use
‘ofa self-contained breathing apparatus with full face piese and postive
pressure mode.
None
None
None
None
None
None
Ceiling 2 ppm (60 minutes) recommended exposure limit for halogenated
‘waste anesthetic gas,
QO SNSICATAND GHEMICAT PROPERTIES
Physical State:
D
‘Molecular Weight:
Boiting Point:
‘Vapor Pressure:
Evaporation Rate:
Liguid
Clear
Coleress
Slight ethereat
Neutral
184.5 pimole
485°C (119.3) at 760 mm He
330mm Hg at 25°C (777)
Not available
Slightly soluble
100 WI
Hazardous Decomposition Products:
Material is stable under recommended storage conditions
Peroxides
Not applicable
‘These products are halogenated compounds (.., hydrochlori and
hydroffourc aids, phosgene)
Ti) TOXICOLOGICAL INFORMATION
e LDw
Ley,
LD
LD
Les,
LDy
Acute Toxicity:
Carcinogenic Effects:
4770 mg/Kg orak-ra
16300 ppm 3H inhalation-at
4280 gikg intrapertoneal-xat
5080 g/kg oral mouse
16800 ppay/3H inhaation-mouse
3030 mg/Kg intraperitoneal-mouse
Cardiovascular effects - may include Muctuaton in heat rate, change ia
blood pressure, chest pain, Respiratory effeets- may include shortness of
breath, bronchospasm, laryngospacms, respiratory depression
Gastrointestinal effects - may include nausea, upset stomach, loss of appa
Nervous System effects - ataxia, tremor, dstubance of speech, lethargy,
hneadache, dizziness, blued vision,
‘Target Organs- nervous system, heat, liver
Not classified or listed by OSHA, IARC, NTP, EU, and! ACGIH. No drug
related carcinogenicftumorigenic effects based on animal data.Motagenie Estects: [Not available
Reproductive Toxicity: [No impairment to ferlty based on animal data. May be fetotoxieat high
«ses based on animal data Epidemiological studies suggest higher than
noma incidences of problem pregnancies (particularly spontaneous
abortions) among expased personnel
FDA Pregnaney Category: c
12) ECOLOGICAL INFORMATIO®
Beotoricity Effect No data available
Bioaccumulation: [No data available
13) DISPOSAL CONSIDERATIONS
Waste Disposal ‘Comply with federal state, and local regulations in the disposal of waste,
Ta) TRANSPORT INFORMATION
bor: [Not regulated for inner packagings not exceeding 5.0L. (13 gallons) net
‘capacity each, Regulated for inner packagings exceeding $.0 (13 gallons)
net capacity cach
DOT shipping name: Aviation regulated ligud, N.O.S, (lsflurane)
UN mumber: UN3334
Packing Group: None
DOT hazard class: 9
ICAOMATA: IATA proper shipping name: Aviation regulated iguid, N.OS, (Isoflurane)
IATA UN number: UN3334
IATA primary hazard class: 9
TATA packing group: None
IATA packing instruction:
‘TDG (Canada): Not regulated
Not regulated
Not regulated
06
15) REGULATORY INFORMATION
Regulated
This produet is excerpt from TSCA,
16) OTHER INFORMATION
New MSDS format.
‘The information abows i believed to be accurate and i intended only a a guide. Piramal Critical Care assumes no
responsibilty for any damages resulting from handling or contact with the above material.